Return On Equity of InMed Pharmaceuticals Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
InMed Pharmaceuticals Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • InMed Pharmaceuticals Inc. Return On Equity for the quarter ending 30 Sep 2025 was -86%, a 31% decline year-over-year.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2025 was -93%, a 29% increase from 2024.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2024 was -131%, a 105% decline from 2023.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2023 was -64%, a 58% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

InMed Pharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -86% -20% -31% 01 Jul 2025 30 Sep 2025
Q2 2025 -93% +37% +29% 01 Apr 2025 30 Jun 2025
Q1 2025 -108% -16% -17% 01 Jan 2025 31 Mar 2025
Q4 2024 -91% +1% +1.2% 01 Oct 2024 31 Dec 2024
Q3 2024 -66% +30% +31% 01 Jul 2024 30 Sep 2024
Q2 2024 -131% -67% -105% 01 Apr 2024 30 Jun 2024
Q1 2024 -92% +40% +30% 01 Jan 2024 31 Mar 2024
Q4 2023 -92% +58% +39% 01 Oct 2023 31 Dec 2023
Q3 2023 -95% +74% +44% 01 Jul 2023 30 Sep 2023
Q2 2023 -64% +87% +58% 01 Apr 2023 30 Jun 2023
Q1 2023 -132% -15% -13% 01 Jan 2023 31 Mar 2023
Q4 2022 -150% -34% -30% 01 Oct 2022 31 Dec 2022
Q3 2022 -170% -56% -49% 01 Jul 2022 30 Sep 2022
Q2 2022 -151% -14% -10% 01 Apr 2022 30 Jun 2022
Q1 2022 -117% +3% +2.7% 01 Jan 2022 31 Mar 2022
Q4 2021 -115% +4% +3.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -114% 0% +0.25% 01 Jul 2021 30 Sep 2021
Q2 2021 -137% -32% -30% 01 Apr 2021 30 Jun 2021
Q1 2021 -121% 01 Jan 2021 31 Mar 2021
Q4 2020 -120% 01 Oct 2020 31 Dec 2020
Q3 2020 -114% 01 Jul 2020 30 Sep 2020
Q2 2020 -105% 01 Apr 2020 30 Jun 2020

InMed Pharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -93% +37% +29% 01 Jul 2024 30 Jun 2025
2024 -131% -67% -105% 01 Jul 2023 30 Jun 2024
2023 -64% +87% +58% 01 Jul 2022 30 Jun 2023
2022 -151% -14% -10% 01 Jul 2021 30 Jun 2022
2021 -137% -32% -30% 01 Jul 2020 30 Jun 2021
2020 -105% 01 Jul 2019 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.